Alert detail
LCD L38779: MolDX: Minimal Residual Disease Testing for Cancer — Palmetto GBA
What changed
MRD cancer testing coverage rules for Palmetto GBA SE states.
Who’s affected: Oncology billing teams · Effective: December 26, 2021
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 10 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.